Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06771739 · ClinicalTrials.gov registry record · NA

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

A NA study, sponsored by Fred Hutchinson Cancer Center.

Not yet
Registry status
NA
Development phase
20
Enrollment target

NCT06771739 is a NA study that has not yet begun recruiting, run by Fred Hutchinson Cancer Center. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06771739, a NA study, has not yet begun recruiting, sponsored by Fred Hutchinson Cancer Center.

NOT YET RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This clinical trial studies whether an unrestricted cash payment program can be used to improve financial and clinical outcomes in early-stage cancer patients with financial concerns. A cancer diagnosis can have poor financial outcomes, and the cost of cancer treatment can lead to high medical debt and financial hardships for the patient and family. Financial hardship during cancer treatment is associated with adverse outcomes including poorer quality of life, lower treatment compliance, more aggressive use of hospital-based care, and worse survival. Newly diagnosed cancer patients with financial concerns may avoid treatment entirely so that they can continue to work and maintain income, provide for their families, or pay rent. An unrestricted cash payment program provides patients with a preloaded cash card once monthly. The patients can choose what to use the card to pay for and may include items like food, rent, or utilities. This provides a period of guaranteed income for the patients and may prevent them from falling into poverty and improve financial and clinical outcomes.

Interventions

  • OTHER Survey Administration
  • OTHER Electronic Health Record Review
  • OTHER Interview
  • OTHER Support

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-08-01
Est. Completion 2026-12-01
Phase NA

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT06771739

The ClinicalTrials.gov registry entry for NCT06771739 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Survey Administration is the first listed.

NCT06771739 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06771739 about?

NCT06771739 is a clinical study titled "A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial". This clinical trial studies whether an unrestricted cash payment program can be used to improve financial and clinical outcomes in early-stage cancer patients with financial concerns. A cancer diagnosis can have poor financial outcomes, and the cost of cancer treatment can lead to high medical debt ...

What is the current status of trial NCT06771739?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-08-01. Estimated completion is 2026-12-01.

What interventions are being tested in trial NCT06771739?

The interventions under investigation include: Survey Administration (OTHER), Electronic Health Record Review (OTHER), Interview (OTHER), Support (OTHER).

Who is sponsoring clinical trial NCT06771739?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.